Benjamin F. Edwards & Company, Inc. Novo Cure LTD Transaction History

Benjamin F. Edwards & Company, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $15,678 - $24,902	-277 Reduced 68.91%	125 $9,000
Q1 2022 May 04, 2022	SELL	$60.15 - $84.52 $36,090 - $50,712	-600 Reduced 59.88%	402 $33,000
Q4 2021 Feb 07, 2022	BUY	$75.08 - $121.99 $66,445 - $107,961	885 Added 756.41%	1,002 $75,000
Q1 2020 May 07, 2020	BUY	$57.05 - $95.75 $969 - $1,627	17 Added 17.0%	117 $8,000
Q4 2019 Feb 06, 2020	BUY	$68.3 - $93.8 $6,830 - $9,380	100 New	100 $8,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.